Gamma-Delta Tcell Engager Platform

Client: Lava Therapeutics

DESCRIPTION

The presence of Vγ9Vδ2 T cells, in many different malignancies, is correlated with a favorable prognosis for survival. Vγ9Vδ2 T cells sense stress signals in tumor cells to induce tumor cell destruction.

LAVA’s bispecific antibodies target and engage Vγ9Vδ2 T cells. The bispecific antibodies enhance the killing potential of Vγ9Vδ2 T cells while leaving the natural mechanism of action intact. Presentation of tumor-associated antigens by Vγ9Vδ2 T cells to ⍺β T cells could lead to long lasting responses.

See also

PH94B

Decoding Cancer Immunology

UroAmplitude

 
 

Our pride and reputation are in everything we deliver.

Visit our process page to see how our award winning animations get created.